BioAtla, Inc.BCABNASDAQ
Loading
Cost of Revenue Over TimeExpanding
Percentile Rank57
3Y CAGR+118.2%
5Y CAGR-9.0%
Studio
Year-over-Year Change

Direct costs attributable to producing goods sold

3Y CAGR
+118.2%/yr
vs -53.8%/yr prior
5Y CAGR
-9.0%/yr
Recent acceleration
Acceleration
+172.0pp
Accelerating
Percentile
P57
Within normal range
vs 5Y Ago
0.6x
Contraction
Streak
1 yr
Consecutive growthExpanding
PeriodValueYoY Change
TTM$12.46M+1246.6%
2024$925000.00-24.2%
2023$1.22M+1.8%
2022$1.20M-
2021$0.00-100.0%
2020$19.93M-23.1%
2019$25.92M-1.5%
2018$26.30M-